The experimental design as practical approach to develop and optimize a formulation of peptide-loaded liposomes

AAPS PharmSciTech

Volumn 11, Issue 2, 2010, Pages 966-975

  Ducat, Emilie ^a   Brion, Michael ^a   Lecomte, Frederic ^a   Evrard, Brigitte ^a   Piel, Geraldine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Design of experiments; Drug delivery system; Freeze thawing; Liposomes; Peptide

Indexed keywords

LIPOSOME; PEPTIDE; DRUG CARRIER;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; ELECTRON MICROSCOPY; ENCAPSULATION; EXPERIMENTAL DESIGN; FREEZE FRACTURE; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRATION; IN VITRO STUDY; IN VIVO STUDY; LIPID MEMBRANE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; CHEMISTRY; PROCEDURES;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG COMPOUNDING; LIPOSOMES; PEPTIDES;

EID: 77954816665     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9463-3     Document Type: Article

References (30)

1. Marson LP, Miller WR, Dixon JM. Angiogenesis and breast cancer. Breast. 1998;7:299-307.
2. Campbell RB. Influence of tumor physiology on delivery of therapeutics. In: Torchilin V, editor. Delivery of protein and peptide drugs in cancer. London: Imperial College Press; 2006. p. 9-35.
3. Morabito A, Sarmiento R, Bonginelli P, Gasparini G. Antiangiogenic strategies, compounds, and early clinical results in breast cancer. Crit Rev Oncol Hematol. 2004;49:91-107.
4. Scappaticci FA. Mechanisms and future directions for angiogenesis-based cancer therapies. J Clin Oncol. 2002;20:3906-27.
5. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:49-257.
6. Torchilin V. Anti-cancer proteins and peptides in liposomes. In: Torchilin V, editor. Delivery of protein and peptide drugs in cancer. London: Imperial College Press; 2006. p. 155-82.
7. Katanasaka Y, Ida T, Asai T, Maeda N, Oku N. Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes. Int J Pharm. 2008;6:219-24.
8. Zhou XH, Li Wan Po A. Peptide and protein drugs: I. Therapeutics applications, absorption and parenteral administration. Int J Pharm. 1991;75:97-115.
9. Banga AK, Chien YW. Systemic delivery of therapeutics peptides and proteins. Int J Pharm. 1988;48:15-50.
10. Zhou XH, Wan Pof AL. Peptide and protein drugs: I. Therapeutics applications, absorption and parenteral administration. Int J Pharm. 1991;75:97-115.
11. Hanato J, Kuriyama K, Mizumoto T, Debari K, Hatanaka J, Onoue S, et al. Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect. Int J Pharm. 2009;382:111-6.
12. Petrikovics I, Budai M, Baskin SI, Rockwood GA, Childress J, Budai L, et al. Characterization of liposomal vesicles encapsulating rhodanese for cyanide antagonism. Drug Deliv. 2009;16:312-9.
13. Klibanov AL, Torchilin VP, Zalipsky S. Long-circulating sterically protected liposomes. In: Torchilin VP, Weissig V, editors. Liposomes, 2nd edn, a practical approach. New York: Oxford University Press; 2003. p. 231-65.
14. Dos Santos SN, Allen C, Doppen AM, Anantha M, Cox KA, Gallagher RC, et al. Influence of poly (ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta. 2007;1768:1367-77.
15. Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm. 2009;71:431-44.
16. Maeda H, Bharate GY, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. 2008;71:409-19.
17. Greish K, Iyer AK, Fang J, Kawasuji M, Maeda H. Enhanced permeability and retention (EPR) effect and tumor selective delivery of anticancer drugs. In: Torchilin VP, editor. Delivery of protein and peptide drugs in cancer. London: Imperial College Press; 2006. p. 37-52.
18. Vatanara A, Rouholamini Najafabadi A, Gilani K, Asgharian R, Darabi M, Rafiee-Tehrani M. A Plackett-Burman design for screening of the operation variables in the formation of salbutamol sulphate particles by supercritical antisolvent. J Supercrit Fluids. 2007;40:111-6.
19. Hyenstrand P, Metcalf JS, Beattie KA, Codd GA. Effects of adsorption to plastics and solvent conditions in the analysis of the cyanobacterial toxin microcystin-LR by high performance liquid chromatography. Water Res. 2001;35:3508-11.
20. John H, Walden M, Schafer S, Genz S, Forssmann WG. Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography-mass spectrometry. Anal Bioanal Chem. 2004;378:883-97.
21. Sallberg M, Blixt M, Zhang ZX, Ekstrand J. Passive adsorption of immunologically active and inactive synthetic peptides to polystyrene is influenced by the proportion of non-polar residues in the peptide. Immunol Lett. 1995;46:25-30.
22. Grohganz H, Rischer M, Brandl M. Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface. Eu J Pharm Sci. 2004;21:191-6.
23. Ramaldes GA, Deverre J.-R., Grognet J.-M., Puisieux F, Fattal E. Use of an enzyme immunoassay for the evaluation of entrapment efficiency and in vitro stability in intestinal fluids of liposomal bovine serum albumin. Int J Pharm. 1996;143:1-11.
24. Katanasaka Y, Ida T, Asai T, Maeda N, Oku N. Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes. Int J Pharm. 2008;360:219-24.
25. Fransen GJ, Salemink P J M, Crommelin D J A. Critical parameters in freezing of liposomes. Int J Pharm. 1986;33:27-35.
26. Talsma H, Van Steenbergen MJ, Crommelin D J A. The cryopreservation of liposomes. III: almost complete retention of a watersoluble marker in small liposomes in a cryoprotectant containing dispersion after a freezing/thawing cycle. Int J Pharm. 1991;77:119-26.
27. Siow LF, Rades T, Lim MH. Characterizing the freezing behavior of liposomes as a tool to understand the cryopreservation procedures. Cryobiology. 2007;55:210-21.
28. Holovati JL, Gyongyossy-Issa MI, Acker JP. Effects of trehaloseloaded liposomes on red blood cell response to freezing and post-thaw membrane quality. Cryobiology. 2009;58:75-83.
29. Higgins J, Hodges NA, Olliff CJ, Phillips AJ. Factors influencing cryoprotective activity and drug leakage from liposomes after freezing. J Pharm Pharmacol. 1986;38:259-63.
30. Zuidam JZ, de Vrueh R, Crommelin DJA. Characterization of liposomes. In: Torchilin VP, Weissig V, editors. Liposomes, 2nd edn, a practical approach. New York: Oxford University Press; 2003. p. 31-78.